(19)
(11) EP 4 815 923 A1

(12)

(43) Date of publication:
07.10.2026 Bulletin 2026/41

(21) Application number: 24898751.3

(22) Date of filing: 27.11.2024
(51) International Patent Classification (IPC): 
A61K 9/16(2006.01)
A61K 47/69(2017.01)
A61P 25/28(2006.01)
A61K 9/1275(2025.01)
(52) Cooperative Patent Classification (CPC):
A61K 9/1275; A61P 25/28
(86) International application number:
PCT/US2024/057721
(87) International publication number:
WO 2025/117721 (05.06.2025 Gazette 2025/23)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 27.11.2023 US 202363603090 P

(71) Applicant: Massachusetts Institute of Technology
Cambridge, MA 02139-4301 (US)

(72) Inventors:
  • TSAI, Li-huei
    Cambridge, MA 02138 (US)
  • PINALS, Rebecca
    Boston, MA 02114 (US)
  • LOZANO CRUZ, Claudia, Fernanda
    Boston, Massachusetts 02114 (US)

(74) Representative: Hoffmann Eitle 
Patent- und Rechtsanwälte PartmbB Arabellastraße 30
81925 München
81925 München (DE)

   


(54) RECONSTITUTED LIPOPROTEIN PARTICLES TO RESCUE LIPID DEFECTS IN THE ALZHEIMER'S BRAIN